{"id":"https://openalex.org/W7096515571","doi":null,"title":"Summary","display_name":"Summary","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7096515571"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.371.6319","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.371.6319","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.metamouse.com/links/Schmitt-2002.Cell.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7096515571"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Clemens A. Schmitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clemens A. Schmitt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014354861","display_name":"Jordan S. Fridman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan S. Fridman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083408391","display_name":"Meng Yang","orcid":"https://orcid.org/0000-0001-5630-6357","observed_orcids":["https://orcid.org/0000-0001-5630-6357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Soyoung Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soyoung Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5061291030","display_name":"Eugene Baranov","orcid":"https://orcid.org/0000-0003-1793-6676","observed_orcids":["https://orcid.org/0000-0003-1793-6676"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugene Baranov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.16539999842643738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.9679999947547913},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8709999918937683},{"id":"https://openalex.org/keywords/p16ink4a","display_name":"p16INK4a","score":0.972000002861023},{"id":"https://openalex.org/keywords/arf","display_name":"ARF","score":0.8579999804496765},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.6919999718666077},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8560000061988831},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.7300000190734863},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8050000071525574},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8199999928474426},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.984000027179718},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.6380000114440918},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.8458999991416931},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6326000094413757},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.6139000058174133},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5839999914169312},{"id":"https://openalex.org/C2779523775","wikidata":"https://www.wikidata.org/wiki/Q9075999","display_name":"Cellular senescence","level":4,"score":0.5428000092506409},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4722999930381775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4203000068664551},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4180000126361847},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.40799999237060547},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37540000677108765},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3237000107765198},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.30550000071525574},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.2854999899864197},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2615000009536743},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.25360000133514404},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25209999084472656}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.371.6319","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.371.6319","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.metamouse.com/links/Schmitt-2002.Cell.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990161819","https://openalex.org/W2105571100","https://openalex.org/W2314823710","https://openalex.org/W2014501282","https://openalex.org/W1964781873","https://openalex.org/W2029958623","https://openalex.org/W2089487644","https://openalex.org/W2062907993","https://openalex.org/W1044392782","https://openalex.org/W2164559478"],"abstract_inverted_index":{"p53":[0,31,37,75],"and":[1,6,32,69,72],"INK4a/ARF":[2,39],"mutations":[3,78],"promote":[4],"tumorigenesis":[5],"drug":[7],"resistance,":[8],"in":[9,50,114],"part,":[10],"by":[11,24,30],"disabling":[12],"apoptosis.":[13],"We":[14],"show":[15],"that":[16],"primary":[17],"murine":[18],"lymphomas":[19],"also":[20],"re-spond":[21],"to":[22,47,81,111],"chemotherapy":[23,99],"engaging":[25],"a":[26,55,60,82,94],"senescence":[27,70,92,109],"program":[28],"controlled":[29],"p16INK4a.":[33],"Hence,":[34],"tumors":[35,53,88,103],"with":[36,104],"or":[38,76],"mutations\u2014but":[40],"not":[41],"those":[42,101],"lacking":[43],"ARF":[44],"alone\u2014respond":[45],"poorly":[46],"cyclophosphamide":[48],"therapy":[49],"vivo.":[51,115],"Moreover,":[52],"harboring":[54,102],"Bcl2-mediated":[56],"apoptotic":[57],"block":[58],"undergo":[59],"drug-induced":[61,91],"cy-tostasis":[62],"involving":[63],"the":[64],"accumulation":[65],"of":[66,90],"p53,":[67],"p16INK4a,":[68],"markers,":[71],"typically":[73],"acquire":[74],"INK4a":[77],"upon":[79],"progression":[80],"terminal":[83],"stage.":[84],"Finally,":[85],"mice":[86],"bearing":[87],"capable":[89],"have":[93],"much":[95],"better":[96],"prognosis":[97],"following":[98],"than":[100],"se-nescence":[105],"defects.":[106],"Therefore,":[107],"cellular":[108],"con-tributes":[110],"treatment":[112],"outcome":[113]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7096515571","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-27T00:00:00"}
